Aerie Pharmaceuticals Inc - AnnualReports.com
Eye disease drug firm Aerie Pharma acquires Spanish company for $10M | WRAL TechWire
Compliance Program | Aerie Pharmaceuticals, Inc.
Aerie Pharma (AERI) Falls on Glaucoma Eye Drop Safety Concerns - TheStreet
Durham-based Aerie Pharma sees positive study results for eye pressure drug | WRAL TechWire
Aerie
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Aerie Pharmaceuticals to Present at Two Investor Conferences in March | Business Wire
Cantor Initiates Aerie Pharma At Buy: 'Wouldn't Be Surprised If Aerie Became Takeover Candidate'
Aerie Pharmaceuticals - Crunchbase Company Profile & Funding
Aerie-Pharma -
Aerie Pharma (AERI) Provides 2020 Company and Guidance Update Associated with COVID-19
Ophthalmology Innovation Showcase 1 - Aerie Pharmaceuticals
Should Aerie Pharmaceuticals Inc (AERI) be in Your Portfolio? - InvestorsObserver
Investor Relations | Aerie Pharmaceuticals, Inc
Durham's Aerie Pharma raises $316.5M, to use funds for eye disease drug development | WRAL TechWire
Aerie in Europe - EuroTimes
Aerie Pharma to use DSM polymers to develop eye drug delivery tech
Aerie Pharma on go with mid-stage study of eye drop for dry eye (NASDAQ:AERI) | Seeking Alpha
Rx Item-RHOPRESSA 0.02 % O/S 2.5 ML netarsudil mesylate DROPS BY AERIE PHARMA
Aerie Pharmaceuticals (AERI) Investor Presentation - Slideshow (NASDAQ:AERI) | Seeking Alpha
AERIE PHARMACEUTICALS, INC. : AERI Stock Price | MarketScreener
Aerie-Pharma -
Aerie Pharma: Finding Value In The Ophthalmic Space (NASDAQ:AERI) | Seeking Alpha
Aerie Pharma: Significantly Derisked (NASDAQ:AERI) | Seeking Alpha
Rise in the sentiment of investors in Aerie Pharmaceuticals INC. – Medgazette 24
Aerie Pharma appoints Richard Rubino as CFO | Procurement & Supply Chain | Healthcare Global
